Milk Versus a Pea-based Beverage for Bone and Muscle Health in Young Athletes

November 25, 2022 updated by: Phil Chilibeck, University of Saskatchewan

Milk Versus a Pea-based Beverage for Increasing Muscle Mass and Bone Mineral Density During Resistance Training in Adolescent Boys and Girls

Canada's Food Guide places an increased emphasis on plant-based proteins; however, Canadians who consume a plant-based diet may be compromised because of intake of lower-quality protein. Consumption of high-quality protein is important during growth and development, especially in highly active individuals. The study will compare milk (i.e. high quality protein) to a pea-based beverage (i.e. lower quality plant-based protein) in adolescent boys and girls who are engaged in resistance-training programs as part of their athletic training. One-hundred and fourteen adolescent boys and girls (12-17y of age) will be divided into groups that consume milk, a pea-beverage, or a carbohydrate (sugar) beverage after resistance training sessions performed three times per week for six months. It is predicted that the group consuming milk will have greater increases in muscle mass, strength, and bone density, and greater reductions in fat mass compared to the groups consuming a pea-based or carbohydrate beverages.

Study Overview

Detailed Description

Milk protein is important especially for very active people and in the context of plant-based diets, which are lower in protein quality. The purpose of the study is to compare the effectiveness of milk supplementation to pea-beverage supplementation during resistance training programs for increasing lean tissue mass in adolescent boys and girls. Secondary and tertiary outcomes include fat mass, bone mineral density, and muscular strength. It is hypothesized that milk supplementation during resistance training will be more effective than plant-based proteins (i.e. pea-beverage) for increasing muscle mass, reducing fat mass, and improving bone mineral outcomes in adolescent boys and girls. One-hundred and fourteen boys and girls (aged 12-17y) who are currently enrolled in resistance training programs (3 times per week for 6 months) as part of their competitive athletic programs will be stratified by sex and maturity status before being randomized to three groups: 1) 1% chocolate milk supplementation; 2) pea-based beverage; 3) carbohydrate beverage (placebo control). Beverages will be consumed during recovery from each resistance training session (i.e. 250 ml immediately after training and 250 ml one hour later to optimize post-exercise protein synthesis) over the six-month intervention. It is anticipated that milk supplementation will be more effective than plant-based protein supplementation.

Study Type

Interventional

Enrollment (Anticipated)

114

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada, S7N5B2
        • Recruiting
        • University of Saskatchewan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently participating in a resistance-training program 3 times per week
  • Female participants must have reached menarche

Exclusion Criteria:

  • Have taken any nutritional supplement (e.g., protein, creatine, amino acids) within the past month
  • Currently taking anabolic steroids or oral corticosteroids
  • Allergies to dairy, almonds, cashews, or peas

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1% chocolate milk
250 ml of 1% chocolate milk consumed immediately after resistance training sessions + 250 ml of chocolate milk consumed 1 hour after resistance training sessions
1% chocolate milk
Pea-based beverage
Maltodextrin placebo
Active Comparator: Pea-based beverage
250 ml of pea beverage consumed immediately after resistance training sessions + 250 ml of pea beverage consumed 1 hour after resistance training sessions
1% chocolate milk
Pea-based beverage
Maltodextrin placebo
Placebo Comparator: Placebo: Low protein plant-based beverage
250 ml of placebo beverage consumed immediately after resistance training sessions + 250 ml of placebo beverage consumed 1 hour after resistance training sessions
1% chocolate milk
Pea-based beverage
Maltodextrin placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in lean tissue mass (kg)
Time Frame: 6 months
Lean tissue mass measured by dual energy X-ray absorptiometry
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in fat mass (kg)
Time Frame: 6 months
Fat mass measured by dual energy X-ray absorptiometry
6 months
Change in lumbar spine bone mineral density (g/cm-squared)
Time Frame: 6 months
Lumbar spine bone mineral density measured by dual energy X-ray absorptiometry
6 months
Change in hip bone mineral density (g/cm-squared)
Time Frame: 6 months
Hip bone mineral density measured by dual energy X-ray absorptiometry
6 months
Change in bench press strength (kg)
Time Frame: 6 months
Bench press strength predicted from resistance lifted for 6-10 repetitions
6 months
Change in squat strength (kg)
Time Frame: 6 months
Squat strength predicted from resistance lifted for 6-10 repetitions
6 months
Change in cross-sectional moment of inertia at the hip (cm to the power of 4)
Time Frame: 6 months
Cross-sectional moment of inertia measured by dual energy X-ray absorptiometry
6 months
Change in section modulus at the hip (cm to the power of 3)
Time Frame: 6 months
Section modulus measured by dual energy X-ray absorptiometry
6 months
Change in cross-sectional area at the hip (cm-squared)
Time Frame: 6 months
Cross-sectional area measured by dual energy X-ray absorptiometry
6 months
Change in cortical thickness at the hip (cm)
Time Frame: 6 months
Cortical thickness measured by dual energy X-ray absorptiometry
6 months
Change in buckling ratio at the hip (no units)
Time Frame: 6 months
Buckling ratio measured by dual energy X-ray absorptiometry
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2022

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

August 31, 2023

Study Registration Dates

First Submitted

May 14, 2022

First Submitted That Met QC Criteria

May 14, 2022

First Posted (Actual)

May 19, 2022

Study Record Updates

Last Update Posted (Actual)

November 30, 2022

Last Update Submitted That Met QC Criteria

November 25, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Atrophy

Clinical Trials on Nutritional supplementation during a 6 month resistance training program

3
Subscribe